Organigram

Organigram Global Inc. is a Canadian cannabis company headquartered in Moncton, New Brunswick. It produces and sells cannabis and cannabis-derived products, including dried flower, pre-rolls, vapes, concentrates, oils, and edibles, for both the adult-use and medical markets. Revenue is generated through sales to provincial cannabis boards, direct sales to medical patients, and exports and partnerships in certain international markets. The company has a production facility in Moncton. In March 2025, investors approved a rebranding from Organigram Holdings to Organigram Global. In 2023, the company reported a quarterly profit of $5.3 million, reversing a $1.3 million loss a year earlier, as revenue rose to $43.3 million from $30.4 million and margins improved. In November 2025, Organigram announced that James Yamanaka, a former executive at British American Tobacco, would become CEO effective around January 15, 2026, and join the board.

Organigram Inc. is a Canadian cannabis company with a production facility in Moncton, New Brunswick. The company produces and sells cannabis and cannabis-derived products, including dried flower, pre-rolls, vapes, concentrates, oils, and edibles, for both the adult-use and medical markets. Revenue is generated through sales to provincial cannabis boards, direct sales to medical patients, and exports and partnerships in certain international markets. In 2023, the company reported a quarterly profit of $5.3 million, reversing a $1.3 million loss a year earlier, as revenue rose to $43.3 million from $30.4 million and margins improved. On March 24, 2025, Organigram investors approved rebranding from Organigram Holdings to Organigram Global. In November 2025, the company announced that James Yamanaka, a former executive at British American Tobacco, was being appointed CEO effective around January 15, 2026, and that he would also join the company’s board.

• Reported quarterly profit of $5.3 million, reversing a $1.3 million loss a year earlier, as revenue rose to $43.3 million from $30.4 million.

• Investors approved rebranding from Organigram Holdings to Organigram Global.

• Announced appointment of James Yamanaka as CEO effective around January 15, 2026.

Canadian licensed cannabis producer serving adult-use and medical markets, with growing international reach.

• Dried flower

• Pre-rolls

• Vapes

• Concentrates

• Oils

• Edibles

• 2021.05.03

  Reported2021.05.03

  Organigram CEO Greg Engel steps down[2]Organigram 首席执行官 Greg Engel 离任winnipegfreepress.com

  Organigram Holdings said CEO Greg Engel was stepping down. The company did not provide details about his departure; he would continue as a special adviser to the board during a transition period.

• 2021.05.03

  Reported2021.05.03

  Organigram appoints Peter Amirault as interim executive chair[2]Organigram 首席执行官 Greg Engel 离任winnipegfreepress.com

  Organigram appointed board chairman Peter Amirault as executive chair on an interim basis, overseeing day-to-day management until a new CEO is named.

• 2021.03.11

  Reported2021.03.11

  BAT subsidiary to acquire 19.9% stake in Organigram Holdings[3]BAT子公司将收购Organigram Holdings 19.9%股权finanznachrichten.de

  A BAT subsidiary was reported as set to acquire a 19.9% equity stake in Organigram Holdings for approximately £126 million, becoming its largest shareholder and gaining the ability to appoint two directors.

• 2021.03.11

  Reported2021.03.11

  BAT and Organigram sign strategic collaboration agreement[3]BAT子公司将收购Organigram Holdings 19.9%股权finanznachrichten.de

  BAT Group and Organigram signed a strategic collaboration agreement to establish a Centre of Excellence focused on developing cannabis products, initially cannabidiol; the companies will contribute staff and license certain intellectual property to each other.

• 2020.08.18

  Organigram joins Shoppers medical cannabis tracking pilot[4]Organigram加入Shoppers医用大麻追踪试点项目newcannabisventures.com

  Organigram announced that it partnered with Medical Cannabis by Shoppers on Phase 2 of Shoppers’ pilot program, powered by software partner TruTrace. Organigram will supply cannabis products for the tracking program.

• 2019.11.08

  Organigram wins Canadian Cannabis Award for Rossignol oil[5]Organigram的Rossignol油品获加拿大大麻奖newcannabisventures.com

  Organigram was honoured at the Canadian Cannabis Awards Gala in Toronto on November 8 with the Top Product Award in the High THC Bottled Oil Category for its medical product, Rossignol.

Read more

1. 1Organigram Inc. - Wikipediaen.wikipedia.org
2. 2Organigram 首席执行官 Greg Engel 离任winnipegfreepress.com
3. 3BAT子公司将收购Organigram Holdings 19.9%股权finanznachrichten.de
4. 4Organigram加入Shoppers医用大麻追踪试点项目newcannabisventures.com
5. 5Organigram的Rossignol油品获加拿大大麻奖newcannabisventures.com
6. 6Organigram Wins Top Product Award in High THC Bottled Oil Category at 2019 Canadian Cannabis Awardsfinancialpost.com